Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

about

Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex.

P2860

Q39139268-134B9955-4C9A-4B1B-9F07-5C35241E9CFF Q47222228-1CC13AC9-5059-46A1-A87E-F5DCC0CED767

P2860

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

Item

http://www.wikidata.org/entity/Q36922241

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

@en

type

Item

label

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

@en

prefLabel

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

@en

P1476

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

@en

P2093

Sara Sanz-Blasco

http://www.w3.org/2001/XMLSchema#string

Scott R McKercher

http://www.w3.org/2001/XMLSchema#string

Stuart A Lipton

http://www.w3.org/2001/XMLSchema#string

Xiaofei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.

Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model.

Cytosolic calcium oscillations in astrocytes may regulate exocytotic release of glutamate.

Memory retrieval deficits: alleviation by etiracetam, a nootropic drug.

Glutamate-mediated astrocyte-neuron signalling.

α7 Nicotinic receptor-mediated astrocytic gliotransmitter release: Aβ effects in a preclinical Alzheimer's mouse model.

P304

705-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WNR.0000000000000601

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan C Piña-Crespo

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27183239

http://www.w3.org/2001/XMLSchema#string

P921

astrocyte

P932

4874889

http://www.w3.org/2001/XMLSchema#string

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

about

P2860

P2860

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932